Table 1.
Demographic characteristics of study participants.
| USA | China | Taiwan | Malaysia | Indonesia | India | |
|---|---|---|---|---|---|---|
| Overall | N = 4050 | N = 2797 | N = 1278 | N = 1492 | N = 1507 | N = 1762 |
| Wave | ||||||
| Mar 2020 | 691 (20.0%) | 1070 (33.3%) | -- | -- | -- | -- |
| Jun 2020 | 655 (19.9%) | -- | -- | -- | -- | -- |
| Aug 2020 | 782 (20.0%) | 788 (33.3%) | 645 (50.0%) | 757 (50.0%) | 716 (49.8%) | 805 (50.0%) |
| Oct 2020 | 936 (20.0%) | -- | -- | -- | -- | -- |
| Nov 2020 | 986 (20.0%) | 939 (33.3%) | 633 (50.0%) | 735 (50.0%) | 791 (50.2%) | 957 (50.0%) |
| Age (years) | ||||||
| 18–34 | 1057 (33.8%) | 963 (34.1%) | 523 (28.8%) | 710 (42.8%) | 702 (42.1%) | 795 (43.2%) |
| 35–54 | 1400 (35.0%) | 1165 (39.2%) | 607 (43.2%) | 670 (40.1%) | 676 (40.5%) | 666 (38.1%) |
| ≥55 | 1593 (31.2%) | 669 (26.7%) | 148 (28.0%) | 112 (17.1%) | 129 (17.4%) | 301 (18.8%) |
| Gender | ||||||
| Female | 2128 (50.6%) | 1386 (48.8%) | 701 (52.1%) | 713 (48.3%) | 713 (49.1%) | 824 (48.2%) |
| Male | 1922 (49.4%) | 1411 (51.2%) | 577 (47.9%) | 779 (51.7%) | 749 (50.1%) | 938 (51.8%) |
| Income | ||||||
| <$2000 equivalent | 891 (22.8%) | 276 (10.5%) | 114 (11.0%) | 391 (28.6%) | 908 (61.7%) | 922 (53.6%) |
| ≥$2000 equivalent | 3155 (77.2%) | 2489 (89.5%) | 1113 (89.1%) | 1100 (71.4%) | 599 (38.3%) | 840 (46.5%) |
| Vaccine hesitant | ||||||
| No | 2371 (57.4%) | 1985 (72.9%) | 395 (40.0%) | 904 (59.3%) | 863 (57.0%) | 1200 (68.3%) |
| Yes | 1626 (42.6%) | 758 (27.1%) | 593 (60.0%) | 588 (40.7%) | 644 (43.0%) | 562 (31.7%) |